Exactly what I said in my $AMRN Sunday School Class.
.,,, except for the lack of mention that the FDA will close their eyes to off-label promotion if you have a peer-reviewed publication. But I take your more nebulously made point.
I do often wonder why this avenue of promotion is not used more often. I know that Viet Le is trying to get his recent presentation on the suppressive effects of DHA on the beneficial effects of EPA published. If published, Amarin should be slapping the required statement on such an article and giving it to all physicians. Same with the October 2020 Mineral oil paper in the European Heart Journal. When Amarin has a booth at in-person conferences, these papers should be handed out like so much candy. And given that KM allegedly is the digital marketing genius, he needs to create an electronic library that automatically disseminates select publications to all physicians that sign up for discounts/samples/assistance.
Market Data 
Markets 
AI
